Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01113840 · ClinicalTrials.gov registry record · NA

Prospective Aerobic Reconditioning Intervention Study

A NA study of Heart Failure, sponsored by Wake Forest University.

Completed
Registry status
NA
Development phase
201
Enrollment target
1
Study location

NCT01113840: Completed NA study of Heart Failure, sponsored by Wake Forest University.

NCT01113840 is a NA study of Heart Failure that has completed, run by Wake Forest University. The registered enrollment target is 201 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01113840, a NA study of Heart Failure, has completed, sponsored by Wake Forest University.

COMPLETED
Registry status
NA
Development phase
201 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is : * To determine if aerobic exercise conditioning can improve symptoms, cardiovascular function and quality of life in elderly patients with congestive heart failure. * To describe the baseline clinical characteristics, cardiovascular function and neurohumoral function in elderly patients with congestive heart failure. * To determine the specific cardiovascular and noncardiovascular mechanisms by which symptoms and quality of life may improve following exercise conditioning in elderly patients with congestive heart failure.

Conditions Studied

Interventions

  • BEHAVIORAL Exercise
  • BEHAVIORAL Control

Study Locations (1)

North Carolina

  • Wake Forest Baptist Health - Winston-Salem

Trial Details

FieldValue
Enrollment Target 201 participants
Start Date 1993-07
Est. Completion 2009-12
Phase NA
Wake Forest University

100 total trials

What the finished NCT01113840 record still lists

NCT01113840 is an interventional study that assigns participants to a tested intervention. The registered 201 participants enrollment target is mid-sized for trials with a published cap, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (90% lower).

The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which Exercise is the first listed.

NCT01113840 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT01113840 about?

NCT01113840 is a clinical study titled "Prospective Aerobic Reconditioning Intervention Study". The purpose of this study is : * To determine if aerobic exercise conditioning can improve symptoms, cardiovascular function and quality of life in elderly patients with congestive heart failure. * To describe the baseline clinical characteristics, cardiovascular function and neurohumoral function ...

What is the current status of trial NCT01113840?

This trial is currently completed. It is a NA study. The enrollment target is 201 participants. The study started on 1993-07. Estimated completion is 2009-12.

What conditions does trial NCT01113840 study?

This clinical trial studies the following conditions: Heart Failure.

What interventions are being tested in trial NCT01113840?

The interventions under investigation include: Exercise (BEHAVIORAL), Control (BEHAVIORAL).

Who is sponsoring clinical trial NCT01113840?

This trial is sponsored by Wake Forest University, which has 100 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01113840 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01113840's enrollment target sits among peer trials

201 164th of 397 higher than 234 of 397 other Heart Failure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04422652 · 201 participants · Phase 2

    Combination of Novel Therapies for CKD Comorbid Depression

  • NCT05327114 · 201 participants · Phase 2

    Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  • NCT06099769 · 201 participants · Phase 2

    A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer

  • NCT06274528 · 201 participants · Phase 2

    DORA and LP in Alzheimer's Disease Biomarkers

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01113840, the US trial registry maintained by the National Library of Medicine. NCT01113840 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.